LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance
The acquisition will accelerate Khiron s growth in Europe by controlling the complete value chain for its products and gaining direct access to German.
The acquisition will accelerate Khiron s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmaciesThe acquisition will provide Khiron.
In Q1 2022, Khiron expects to surpass 1 million CAD in medical cannabis revenues in the United Kingdom ("UK") aloneTotal untapped potential for cannabis patients in the UK exceeds 1M patientsSupported
LONDON, Feb. 10, 2022 /PRNewswire/ Warburg Pincus, a leading global growth investor, today announced the acquisition of Pharma Intelligence, a leading provider of specialist intelligence